• Fri, May 8, 2020

Kennen MacKay Maintained (ABEO) at Buy with Decreased Target to $175 on, May 8th, 2020

Kennen MacKay of RBC Capital, Maintained "Abeona Therapeutics Inc." (ABEO) at Buy with Decreased Target from $275 to $175 on, May 8th, 2020.

Kennen has made no other calls on ABEO in the last 4 months.



There is 1 other peer that has a rating on ABEO. Out of the 1 peers that are also analyzing ABEO, 0 agree with Kennen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kennen


  • Mani Foroohar of "SVB Leerink" Maintained at Buy and Held Target at $150 on, Monday, February 10th, 2020

Like: 👍